Table 6.
Outcome parameters of the control and case group patients.
| Controls | Cases | P | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| 1 Normal (n=39) | 2 CP (n=26) | 3 All (N=65) | 4 Normal (n=35) | 5 CP (n=34) | 6 All (N=69) | 1 vs. 4 | 2 vs. 5 | 3 vs. 6 | ||
| Progressive injury | Hemorrhagic | 18 (46.2) | 13 (50) | 31 (47.7)* | 10 (28.6) | 11 (32.4) | 21 (30.4)* | 0.119 | 0.167 | 0.040* |
| Ischemic | 6 (15.4) | 14 (53.8) | 20 (30.8) | 5 (14.3) | 13 (38.2) | 18 (26.1) | 0.894 | 0.228 | 0.548 | |
| Edematous | 2 (5.1) | 3 (11.5) | 5 (7.7) | 4 (11.4) | 6 (17.6) | 10 (14.5) | 0.322 | 0.511 | 0.212 | |
|
| ||||||||||
| Re-intervention | 6 (15.8) | 10 (40)* | 16 (25.4) | 5 (14.3) | 4 (12.9)* | 9 (13.6) | 0.858 | 0.020* | 0.091 | |
|
| ||||||||||
| Length of hospital stay (survivors) | 17 (10–27) | 25 (14–32) | 22 (10.75–27.25) | 17 (9.75–25.75) | 19 (11–24.5) | 17 (11–24) | 0.683 | 0.101 | 0.277 | |
|
| ||||||||||
| GCS | Day 3 | 12 (7–15) | 9 (5–14) | 11 (5–14) | 13 (6–15) | 11.5 (5–15) | 12.5 (5–15) | 0.483 | 0.292 | 0.289 |
| Day 7 | 13 (8.5–15) | 10.5 (5–14.75) | 12 (5–15) | 15 (6–15) | 13 (5.5–15) | 13 (6–15) | 0.294 | 0.271 | 0.205 | |
| At discharge | 15 (12–15) | 14 (8–15) | 15 (10.75–15) | 15 (13.5–15) | 15 (13–15) | 15 (13–15) | 0.386 | 0.190 | 0.158 | |
|
| ||||||||||
| Clinical outcome | Favorable (GOS 4–5) | 19 (48.7) | 4 (15.4) | 23 (35.4) | 19 (54.3) | 13 (38.2) | 32 (46.4) | 0.632 | 0.052 | 0.196 |
| Poor (GOS 1–3) | 20 (51.3) | 22 (84.6) | 42 (64.6) | 16 (45.7) | 21 (61.8) | 37 (53.6) | ||||
|
| ||||||||||
| Death | 4 (10.3) | 11 (42.3) | 15 (23.1) | 5 (14.3) | 13 (38.2) | 18 (26.1) | 0.596 | 0.750 | 0.686 | |
Continuous variables are reported as median (interquartile range); categorical variables are reported in terms of frequency (percentage). Superscript numbers (1 to 6) mark columns to clarify comparisons.
*
Statistically significant differences.
CP – coagulopathy; GCS – Glasgow coma score; GOS – Glasgow outcome score.